This chart includes policy and legislative successes at the state level.
| State | Year Introduced | Issue | Type (Letter, Regulation Comments, Legislation) | Bill Number & Title | Description | Position Statements & Coalition and Triage Cancer Letter of Support | Status | ||
|---|---|---|---|---|---|---|---|---|---|
| Colorado | 2025 | Access to Care | Legislation | https://leg.colorado.gov/bills/sb25-296 | SB25-296 - Insurance Coverage for Breast Cancer Examinations | This bill clarifies that diagnostic and supplemental breast examinations, in addition to regular breast cancer screening, do not require cost sharing by the patient. | Support | Signed into law on 05/29/2025 | |
| Arkansas | 2025 | Genetics | Legislation | https://arkleg.state.ar.us/Bills/Detail?id=HB1079&ddBienniumSession=2025%2F2025R | HB1079 - To Mandate Coverage for Genetic Testing for an Inherited Gene Mutation for Certain Individuals; And to Mandate Coverage for Evidence-Based Cancer Imaging for Certain Individuals. | This bill will require most health insurers to cover genetic testing for those with a personal or family history of cancer, and coverage of the associated guideline-recommended cancer screenings with no patient cost-sharing. | Support | Signed into law as Act 860 on 4/17/2025 | |
| Arkansas | 2025 | Access to Care | Legislation | https://arkleg.state.ar.us/Bills/Detail?id=SB123&ddBienniumSession=2025%2F2025R | SB123 - To Amend the Law Concerning Coverage for Mammograms and Breast Ultrasounds | This bill will will require most health insurers to cover guideline-recommended breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. | Support | Signed into law as Act 553 on 4/14/2025 | |
| Connecticut | 2025 | Biomarker Testing | Legislation | https://www.cga.ct.gov/asp/CGABillStatus/CGAbillstatus.asp?which_year=2025&selBillType=Bill&bill_num=HB6771 | CT HB6771 - An Act Requiring Health Insurance Coverage for Biomarker testing | This bill would require health insurance plans to provide coverage for biomarker testing for the purpose of diagnosis, treatment, appropriate management or ongoing monitoring of an insured's disease or condition. | Support | Signed by governor 6/3/2025 | |
| Maryland | 2025 | Genetics | Legislation | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1007?ys=2025RS | MD HB1007 - Disability and Life Insurance - Medical Information (Genetic Testing Protection Act) | This Act would prohibit life insurance or disability insurance carriers from unfairly discriminating against individuals based on medical information and ensure that patients cannot be penalized or charged higher premiums for choosing not to share their genetic information. | Support | Approved by governor 5/6/2025 | |
| Vermont | 2025 | Access to Care | Legislation | https://legislature.vermont.gov/bill/status/2026/S.30 | VT S.30 - An act relating to updating and reorganizing the health insurance statutes | This bill requires health insurance plans to provide coverage for prostate cancer screenings consistent with the recommendations of the CDC or upon recommendation of the covered individual’s health care professional. | Support | Signed by governor 5/1/2025 | |
| Montana | 2025 | Medicaid | Legislation | https://bills.legmt.gov/#/laws/bill/2/LC0953?open_tab=sum | HB 245: Revise the Montana HELP Act workforce development provisions and termination date | This bill removed the sunset provision that would have ended Montana's Medicaid expansion in 2025, protecting Medicaid in Montana for years to come. | Support | Signed by governor 3/27/2025 | |
| New Jersey | 2024 | Biomarker Testing | Legislation | https://www.njleg.state.nj.us/bill-search/2024/A4163 | A4163: An Act concerning health insurance coverage for biomarker precision medical testing | This bill requires state-regulated health insurance providers, Medicaid, and the SHBP and SEHBP to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an individual’s disease or condition when the test is supported by medical and scientific evidence. | Support | Signed into law 4/23/2025 | |
| District of Columbia | 2023 | Insurance Coverage | Legislation | https://lims.dccouncil.gov/Legislation/B25-0229 | B25-0229, The Cost-Free Coverage for Prostate Cancer Screening Amendment Act of 2023 | The bill would require insurers to provide coverage for prostate cancer screening in accordance with evidence-based guidelines, to include no less than one prostate-specific antigen test and digital rectal exam per year. Insurers would also be prohibited from imposing any deductible, coinsurance, copayment, or other cost-sharing requirement when a patient receives a prostate-specific antigen test and digital rectal exam. | Support | Introduced 3/20/2023; Referred to Committee on Business and Economic Development 4/4/2023; Public Hearing 9/28/23; transmitted to congress 11/1/24; Dec 17, 2024Law Number L25-0235 Effective from Dec 17, 2024 | |
| Arkansas | 2023 | Biomarker Testing | Legislation | https://www.arkleg.state.ar.us/Bills/Detail?id=hb1121&ddBienniumSession=2023%2F2023R | HB 1121: Concerning Coverage For Biomarker Testing For Early Detection And Management For Cancer Diagnoses. | Require Health Insurance coverage of Biomarker Testing for cancer diagnoses | Support | Signed into law 4/4/23 | |
| California | 2023 | Biomarker Testing | Legislation | https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240SB496 | SB496 Biomarker Testing | This bill requires a health care service plan contract or health insurance policy issued, amended, or renewed on or after July 1, 2024, to provide coverage for medically necessary biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring to guide treatment decisions if the test is supported by medical and scientific evidence. The bill does not require a health care service plan or health insurer to cover biomarker testing for screening purposes unless otherwise required by law. | Support | Effective July 1, 2024 | |
| California | 2023 | Insurance Coverage | Budget Change Proposal | https://www.dhcs.ca.gov/Documents/Budget-Highlights/DHCS-FY-2023-24-GB-Highlights.pdf | 2023-24 Governor’s Budget Department of Health Care Services Highlights | The budget change would add funding for positions to support the implementation of the Cancer Care Equity Act, which was passed in 2022, and allows Medi-Cal patients with a complex cancer diagnosis the ability to request areferral to an NCI (National Cancer Institute) Designated Comprehensive Cancer Center. | Support | https://triagecancer.org/wp-content/uploads/2023/03/SB-987-Budget-item-support-ltr3-5-23.pdf | Final budget included additional funding for the Cancer Care Equity Act |
| Georgia | 2023 | Biomarker Testing | Legislation | https://www.legis.ga.gov/legislation/63669 | HB 85 | Require health benefit policy coverage for biomarker testing if supported by medical and scientific evidence | Support | https://triagecancer.org/wp-content/uploads/2023/05/TC-support-for-GA-HB-85-Biomarker-Testing.pdf | Effective 7/1/2023 |
| Illinois | 2023 | Paid Leave | Legislation | https://www.ilga.gov/legislation/fulltext.asp?DocName=&SessionId=110&GA=102&DocTypeId=SB&DocNum=208&GAID=16&LegID=129513&SpecSess=&Session= | SB208 Paid Leave for All Workers Act | Provide all workers in Illinois with up to 40 hours of paid leave per year for any reason | Support | Effective 1/1/2024 | |
| Kentucky | 2023 | Biomarker Testing | Legislation | https://apps.legislature.ky.gov/record/23rs/hb180.html | HB 180 AN ACT relating to coverage for biomarker testing. | Require Health Insurance coverage of Biomarker Testing | Support | Effective 1/1/2024 | |
| Maryland | 2023 | Biomarker Testing | Legislation | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1217?ys=2023RS | HB1217/SB805 | Require health insurance coverage of Biomarker Testing | Support | Effective 1/1/2024 | |
| Nevada | 2023 | Biomarker Testing | Legislation | https://www.leg.state.nv.us/App/NELIS/REL/82nd2023/Bill/9818/Overview | AB155 | As amended, this bill would require insurance coverage of biomarker testing medically necessary for the ongoing monitoring of a cancer diagnosis. | Oppose as amended | https://triagecancer.org/wp-content/uploads/2023/06/NV-AB155-opposed_senate-finance.pdf | Effective 10/1/23 |
| New Mexico | 2023 | Biomarker Testing | Legislation | https://www.nmlegis.gov/Sessions/23%20Regular/bills/house/HB0073.pdf | HB73 | Require that health plans provide coverage for biomarker testing | Support | Effective 1/1/2024 | |
| New York | 2023 | Biomarker Testing | Legislation | https://assembly.state.ny.us/leg/?default_fld=&leg_video=&bn=S01196&term=2023&Summary=Y&Actions=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y&Memo=Y&Text=Y | S1196/A1673 | Require that health plans provide coverage for biomarker testing | Support | https://triagecancer.org/wp-content/uploads/2023/05/TC-Letters-of-support-for-NY-A-1673-and-S-1196.pdf | Effective 4/1/2024 |
| Oklahoma | 2023 | Biomarker Testing | Legislation | http://www.oklegislature.gov/BillInfo.aspx?Bill=sb513&Session=2300 | SB513 | Require health insurance coverage of Biomarker Testing | Support | https://triagecancer.org/wp-content/uploads/2023/06/OK-partner-letter-final.pdf | Effective 1/1/2024 |
| Texas | 2023 | Biomarker Testing | Legislation | https://capitol.texas.gov/BillLookup/History.aspx?LegSess=88R&Bill=SB989 | SB 989: Relating to health benefit plan coverage for certain biomarker testing | Require health insurance coverage of Biomarker testing | Support | Effective 9/1/2023 |